Scientific Program > Scientific Program

The scientific program of the IWPCT-2017 is composed of 18 invited talks, 5 contributed oral presentations, and 2 poster sessions.

Monday 27^th March

08:30–09:00 Registration

09:00–09:10 Welcome by IWPCT–2017 LOC Chairs

09:10–09:15 Opening by IWPCT ISC Chair

Oral session 1: Chair: Mounir Laroussi, Old Dominion University

09:15–09:45 Georg Isbary, Roche Pharma AG, Germany

• Oncology - from pharmaceutical view

09:45–10:15 Christian Seebauer, University of Greifswald, Germany

• Therapeutic potential of cold atmospheric plasma for the treatment of leukoplakia as intraoral precancerous lesion

10:15–10:45 Colin Young, George Washington University, United States of America

• Intracranial targeting of glioblastoma multiforme with cold atmospheric plasma

10:45–11:15 Coffee break

Oral session 2: Chair: David Graves, University of California Berkeley

11:15–11:45 Robert Short, University of Lancaster, United Kingdom

• The effect of plasma treated media on chromosomal modification in cell division

11:45–12:15 Yoshimichi Nakatsu, Kyushu University, Japan

• Analyses of oxidative mutagenesis and carcinogenesis using genetically modified mice: application to plasma medicine

12:15–13:50 Lunch

Oral session 3: Chair: Annemie Bogaerts, University of Antwerpen

13:50–14:20 Lionel Apetoh, French National Institute of Health and Medical Research (Inserm), France

• Immunogenic tumor cell death and its relevance for cancer treatment

14:20–14:40 Pietro Ranieri, Drexel University, United States of America

• Propagation of plasma anti-tumor effects into tissue: the role of intercellular signaling

14:40–15:00 Theresa Freeman, Thomas Jefferson University, United States of America

• The effects of plasma treatment - assessing immunological methods responsible for tumor eradication

15:00–15:30 Ryo Ono, University of Tokyo, Japan

• Immunotherapy of melanoma in mice using nanosecond pulsed streamer discharge

15:30–16:00 Coffee break

Oral session 4: Chair: Michael Keidar, George Washington University

16:00–16:30 Anne-Laure Bulteau, University of Lyon, France

• Mechanistic insights into the impact of cold atmospheric pressure plasma on human epithelial cell lines

16:30–17:00 Hans-Robert Metelmann, University of Greifswald, Germany

• Head and neck cancer treatment with plasma – clinical experience to support basic research with practical plasma application data

17:00–17:30 Nofel Merbahi, University of Toulouse, France

• Plasma activated medium induce head and neck FaDu cancer cell death

17:30–18:45 Poster session 1

20:00–23:00 Banquet dinner at La Baleine

Tuesday 28^th March

Oral session 5: Chair: Pierre-Marie Girard, Institut Curie

09:00–09:30 Fatima Mechta-Grigoriou, Institut Curie, France

• Role of miR-200 and stromal heterogeneity in ovarian and breast tumours

09:30–10:00 Norman Maitland, University of York, United Kingdom

• Mechanisms of cell death in normal and malignant prostate epithelial cells after treatment with low temperature plasma

10:00–10:30 Marie Dutreix, Institut Curie, France

• DNA repair inhibitors: story of the Dbait discovery from bench to bed

10:30–10:50 Coffee break

Oral session 6: Chair: Hans-Robert Metelmann, University of Greifswald

10:50–11:20 Jerome Canady, US Medical Innovations LLC, United States of America

• Clinical application of cold atmospheric plasma (CAP) and hybrid plasma for the treatment of stage IV gastrointestinal cancers: update

11:20–11:50 Cristina Canal, University of Catalonia, Spain

• Plasma jet selectivity on bone cancer cells and liquid-mediated effects

12:00–13:00 Poster session 2 and/or visit to the Curie Museum

13:00–14:00 Lunch

Oral session 7: Chair: Deborah O’Connell, University of York

14:00–14:20 David Duday, Luxembourg Institute of Science and Technology, Luxembourg

• Can the selectivity of plasma treatment on cancer cells and extracellular vesicles come from the cell's membrane composition?

14:20–14:40 Jiangwei Duan, Huazhong University of Science & Technology, China

• The selective effect of plasma activated medium in an in vitro co-culture of liver cancer and normal cells

14:40–15:00 Ronit Shtrichman, Laboratory of Applied Cancer Research, Israel

• In vivo evaluation of OnCAP device for tumor treatment in the mouse model

15:00–15:30 Yuri Gorbanev, University of Antwerp, Belgium

• Analysis of plasma-exposed aqueous solutions: Reactive plasma regions as sources of RONS

15:30–16:00 Coffee break

Oral session 8: Chair: João Santos Sousa, University of Paris-Saclay

16:00–16:30 Georg Bauer, University of Freiburg, Germany

• Targeting protective catalase of tumor cells with cold atmospheric plasma-treated medium

16:30–17:00 Anthony Delalande, University of Orléans, France

• Investigation of cell membrane permeabilization induced by plasma treatment for drug delivery applications

17:00–17:25 Discussion by IWPCT ISC Chair

17:25–17:30 Closing by IWPCT–2017 LOC Chairs and IWPCT ISC Chair